Nov 6, 2024 at 1:55 AM#41
Saving this for reference. Top-tier content.
35 12LeilaHI, marcus_mpls, DeniseRN_TPA and 32 others
Reply Quote Save Share Report
Nov 6, 2024 at 2:12 AM#42
Slightly tangential to Kidney stone risk on but Dr.EndoIndy reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Last edited: Nov 6, 2024 at 4:12 AM
1 10TinaHashiRN
Reply Quote Save Share Report
Nov 6, 2024 at 2:29 AM#43
Saving this for reference. Quality thread.
13 1emma_london, tammy_FL, Dr.LipidDallas and 10 others
Reply Quote Save Share Report
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsNov 6, 2024 at 2:46 AM#44
Want to share my personal experience related to Kidney stone risk on GLP-1 my since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 247 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 10 months later: I am down 62 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Kidney stone risk on aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
6 4laura_annarbor, JenMemphis, pat_auckland and 3 others
Reply Quote Save Share Report
Nov 6, 2024 at 3:03 AM#45
Relevant to Kidney stone risk on GLP-1 my — here is my latest bloodwork comparison:
Key improvements: A1C 8.4% → 5.5%, triglycerides 193 → 93 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
49 4Dr.GutHealth, amsterdam_pete, LondonLisa and 46 others
Reply Quote Save Share Report